Calbindin 1, Mouse (CABP28K, CALB1, Spot35 protein, Cholecalcin) Control Peptide

Article Name:	Calbindin 1, Mouse (CABP28K, CALB1, Spot35 protein, Cholecalcin) Control Peptide
Biozol Catalog Number:	USB-C0113-10
Supplier Catalog Number:	C0113-10
Alternative Catalog Number:	USB-C0113-10-100
Manufacturer:	US Biological
Category:	Molekularbiologie
Application:	ELISA, WB

A 20-aa peptide sequence within the C-terminal, non-calcium binding domain of mouse D28K . Calcium (Ca+2 or Ca) is the most abundant cation and it is required for many physiological activities such as bone formation and it acts as a second messenger in signal transduction. However only 1% of Ca is present in ionic form in biological fluids. Ca concentration is regulated by calcitropic hormones that act on bone, kidney, and intestine. Extracellular Ca+-levels are sensed and regulated by Calcium Sensing receptor (CASR). When Ca levels are limiting then it must be taken up by active, transcellular pathways comprising (1) Ca++ entry across apical membrane, (2) cytosolic transport of Ca++ across the cell form apical to basolateral membrane facilitated by a family of low mol wt Calcium binding proteins (CABPs) that include vitamin D3-dependent Ca++ binding proteins (calbindin-D9k, Calbindin-28k, Calretinin, Parvalbumin, S100, calmodulin) and finally (3) an active extrusion of Ca++ through basolateral membrane mediated by Ca++-ATPase and Na+-Ca++ exchangers (NCX). Ca++ absorption in intestine and its reabsorption in kidney are carried out by Ca++ Transport (CaT) proteins, CaT-1, CaT-2 or Epithelial Ca Channel (ECAC1/ECAC2/CaT-Like (CaT-L) proteins. Calbindins are Ca-binding proteins belonging to the troponin C superfamily. There are two types of CaBPs: the trigger- and the buffer-CaBPs. The conformation of trigger type CaBPs changes upon Ca2+ binding and exposes regions on protein that interact with target molecules, thus altering their activity. The buffer-type CABP are thought to control the intracellular calcium concentration. CALB28K/Calbindin 1/CALB1 (D28K/Spot35 protein or cholecalcin, rat 261 aa, mouse 261 aa, human 261-aa, chromosome 8q21.3-q22.1) was originally described as 27-kDA induced by vitamin D in the duodenum of chicken. In mammals, it is expressed in the kidney, pancreatic islets, and brain. In brain, its synthesis is independent of vitamin D. CABP28K contains 4 active and 2 inactive EF-hand Ca-binding domains. The gene for CABP28K is clustered in the same region as carbonic anhydrase. The neurons in the brains of patients with Huntington disease are CAB28K depleted. Calbindin-D-28K is found predominantly in subpopulations of central and peripheral nervous system neurons, and in certain epithelial cells involved in Ca2+ transport such as distal tubular cells and cortical collecting tubules of the kidney, and in enteric neuroendocrine cells.

Purity:	Highly purified
Form:	Supplied as a liquid in PBS, pH 7.2